Announcement on Adjusting 2024 Annual Profit Distribution Plan
Filed with SSE · · 2 pages · Chinese
CABIO Biotech (Wuhan) Co. Ltd. on 6ix
Earlier from CABIO Biotech (Wuhan)
- Announcement on Attending 2024 SSE STAR Market Biological Products and CXO Industry Collective Performance Briefing
- Announcement on Changing Enterprise Type
- Announcement on Self-Inspection Report on Purchase and Sale of Shares by Relevant Subjects Related to This Transaction
- Indicative Announcement on Risk of Purchase of Assets and Raising of Supporting Funds through Shares Issuance and Cash Payment and Related Transaction
- Announcement on Preliminary Earnings Estimate for 2024
Later from CABIO Biotech (Wuhan)
- Notice on Convening the 2024 Annual General Meeting
- Announcement on Changing Major Asset Restructuring Project and Audit Signatory Accountant for 2025
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Convening the Q1 2025 Performance Briefing
- Announcement on Reply to the Review Inquiry Letter of Application for Purchasing Assets and Raising Supporting Funds by Issuing Shares and Paying Cash as well as Related Party Transactions
Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.
Follow CABIO Biotech (Wuhan)